Clinical Trial Update: Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients [Phase 2]

View source ↗

Summary

This document provides a Phase 2 clinical trial update on adoptive cell therapy following non-myeloablative chemotherapy in patients with metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Adoptive cell therapy

Snippet

Sponsor: Sheba Medical Center | Conditions: Metastatic Melanoma | Phase 2 | Status: UNKNOWN